BioCentury | May 11, 2018
Company News

Merck, J&J vaccines ready for Ebola outbreak

...2015, FDA approved a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier...
...Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Infectious Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN...
BioCentury | May 9, 2018
Politics & Policy

Merck, J&J vaccines ready for Ebola outbreak

...2015, FDA approved a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier...
...CanSino Biologics Inc. (Tianjin, China), is approved in China to treat Ebola virus infection. Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN...
BioCentury | Aug 22, 2016
Clinical News

Aethlon Medical preclinical data

...In vitro, the Aethlon Hemopurifier led to 95% clearance of Zika virus from cell culture fluid in...
...patients in the U.S. with the Aethlon Hemopurifier. Aethlon Medical Inc. (NASDAQ:AEMD), San Diego, Calif. Product: Aethlon Hemopurifier...
BioCentury | Apr 20, 2015
Clinical News

Aethlon Hemopurifier regulatory update

...Aethlon said it submitted a Humanitarian Use Device (HUD) application to FDA for Aethlon Hemopurifier to treat...
...chronic dialysis (see BioCentury, Jan. 19). Aethlon Medical Inc . (OTCQB:AEMD), San Diego, Calif. Product: Aethlon Hemopurifier...
BioCentury | Jan 19, 2015
Clinical News

Hemopurifier infectious data

...10 evaluable patients with HCV infection in the Indian Extract-1 trial showed that treatment with Hemopurifier...
...U.S. clinical trial of its Hemopurifier therapy. Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Product: Hemopurifier...
BioCentury | Jan 19, 2015
Clinical News

Hemopurifier: Clinical trial started

...Aethlon began an open-label, U.S. clinical trial to evaluate Hemopurifier in about 10 HCV-infected patients with...
...end-stage renal disease (ESRD) receiving chronic dialysis. Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Product: Hemopurifier...
BioCentury | Dec 8, 2014
Clinical News

Hemopurifier regulatory update

...Aethlon said it received updated guidance from FDA that the company can provide Hemopurifier to treat...
...HCV infection, and pandemic threats, including Ebola. Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Product: Hemopurifier...
BioCentury | Nov 10, 2014
Clinical News

Hemopurifier regulatory update

...Aethlon will provide its Hemopurifier under a compassionate use program in the U.S. to treat Ebola...
...absorbs viruses and immunosuppressive toxins from blood. Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Product: Hemopurifier...
BioCentury | Oct 27, 2014
Clinical News

Hemopurifier: Clinical trial start

...Next month, Aethlon said it will begin a U.S. feasibility study to evaluate its Hemopurifier for...
...company also announced a World Health Organization (WHO) worker with Ebola was treated with the Hemopurifier...
...the Frankfurt University Hospital in Frankfurt, Germany. Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Product: Hemopurifier...
BioCentury | May 14, 2012
Clinical News

Hemopurifier: Additional data

...patients with HCV genotype 1 infection in the Indian Extract-1 study showed that treatment with Hemopurifier...
...IU/mL, respectively. In a patient with a moderate baseline viral load of 1.3 million IU/mL, Hemopurifier...
...HCV RNA reduction at day 3. Additionally, Aethlon said that a single 6-hour treatment with Hemopurifier...
Items per page:
1 - 10 of 16